# What Helped, What Harmed, and What Isn’t Known > Peptide Questions: What’s Known and Still Unproved — GHK-Cu, CJC-1295, semaglutide, and thymosin alpha-1 have different benefits and risks. Read what’s known and what the studies can’t tell you. **Your questions / treatment claims need clear answers** Peptides can affect the body in different ways. These answers cover the claims about four peptides, their approval limits, and what the evidence means for you. ## GHK-Cu Repair Findings Don’t Establish Healing Throughout the Body Healing elsewhere hasn't been established with GHK-Cu. Copper is part of this peptide. Reviews described effects on collagen, a protein that gives strength to skin [2][4]. Cells used their genes differently; genes hold cell instructions. Human skin tests mostly involved small groups. Those findings can't prove wider healing for you. ## GHK Alone Lacks the Copper in GHK-Cu Three amino acids join to form GHK; proteins contain these small parts too. GHK-Cu adds copper. Copper can affect collagen, the protein strengthening skin, and skin repair. Getting through the outer skin layer was difficult [1][5]. You can't count entry as proof of healthier skin. ## A Skin Change Doesn’t Prove That Aging Reversed The wider anti-aging claim hasn't been established. Small skin studies found changes while new collagen formed [1][4]. Collagen gives skin its strength; it’s a protein. Lab tests suggested other repair effects [2]. You can't call those results proof that your whole body became younger. ## DAC Helps Keep CJC-1295 in Blood CJC-1295 raises growth hormone from the gland found just under the brain. That gland makes hormones. DAC binds albumin; this protein carries substances around in blood. The peptide lacks this bond without DAC. The longer-lasting form raised growth hormones [9][10]. You can't assume both versions act alike. ## CJC-1295 Blood Tests Didn’t Establish Lasting Health Benefits Small studies found raised growth hormones in blood [8][9][10]. Growth hormone still entered in bursts, with higher levels between bursts. Lasting health gains weren't established. Your unanswered question is whether people's health improved. ## The Early CJC-1295 Tests Could Miss Harm Appearing Later CJC-1295 isn't approved for human treatment. Early tests involved few people and chiefly measured blood hormones [8][9][10]. Raised hormones leave safety questions unanswered. A short test can miss later harm. These tests can't settle long-term safety for you or choose your care. ## CJC-1295 Studies Don’t Establish a Safe Personal Dose These studies haven't established a treatment amount that's safe for you. CJC-1295 isn't approved for treatment, and its versions differ. Research amounts aren't personal prescriptions. Different versions can't be assumed equal. These findings don't supply safe dose instructions for your care. ## Semaglutide Copies a Gut Hormone Affecting Hunger Semaglutide copies GLP-1, a gut hormone that affects appetite and helps control sugar in blood. Insulin is another hormone involved in lowering blood sugar. Certain prescription forms have approved uses. Trials measured patient health [12][13][14]. Those results can't establish the ingredients in an unrelated research product. ## Tablet and Shot Approvals Can Differ Approved uses may differ for a tablet and for a shot. Countries can differ in their approvals too. Some patient trials found weight loss; others found fewer serious problems involving hearts or kidneys [12][13][14]. Your doctor or pharmacy can explain what your prescription is approved to treat. ## The Weight Trial Found More Loss Than With Placebo By acting like GLP-1, semaglutide changes appetite and blood sugar control. The stomach empties food less quickly too. Brain tests involved rats and mice [16]. STEP 1 studied overweight adults without diabetes [14]. They lost more weight with semaglutide than placebo, containing no active drug. The patient result tells you more than the animal tests. ## Thymosin Alpha 1 Can Alter the Body’s Defenses Thymosin alpha-1 changes immune cells, the cells helping the body resist infections. Researchers examined cancer and infection, including sepsis [19][21]. Sepsis is infection causing a dangerous reaction that can harm organs. Some effects may strengthen defenses or limit overreactions. You still need proof of help in patients. ## US Medicine Sales of Thymosin Alpha 1 Aren’t Approved US sale of this peptide as medicine isn't approved [19]. Thymalfasin is a lab-made medicine used abroad. Use elsewhere doesn't check the contents of another product. A research label doesn't give medical approval or prove safety. Your benefit can't be established from a similar name. --- An independent reading of peptide evidence, where methods and uncertainty stay attached to every claim—not a shop, clinic, or prescription.